[1]
M. Sribanphai and S. Chusiri, “INCIDENCE AND RISK FACTORS ASSOCIATED WITH NEUROLOGICAL ADVERSE REACTIONS IN FOCAL EPILEPSY PATIENTS USING LEVETIRACETAM”, Thai Bull Pharm Sci, vol. 19, no. 2, pp. 165–175, May 2024.